← FDA Drug Approvals (Drugs@FDA)

LUMIGAN

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2010-08-31

Drug application

FDA Application #

NDA022184

Application type

New Drug Application

Brand name

LUMIGAN

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2010-08-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown